Plus Therapeutics, Inc. ( PSTV) - Stock Earnings
PSTV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.4 million USD | 1.4 million USD |
| 2025Q4 | -5.7 million USD | 1.4 million USD |
| 2026Q1 | -6.9 million USD | 1.0 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PSTV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.3 million USD | 4.9 million USD |
| 2024 | -13.0 million USD | 5.8 million USD |
| 2025 | -22.4 million USD | 5.2 million USD |
| 2026 Est. | — | — |
PSTV
Price: $5.42
52 week price:
Payout Ratio Range:
Earnings Per Share: 21.45 USD
P/E Ratio: 0.30
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 204800
Market Capitalization: 44.1 million